⌘K
Loading ticker…
As of 2026-08-24, EyePoint, Inc. Common Stock (EYPT) has a 3-month relative strength percentile of 4 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 28. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.9%, relative volume 0.68×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
EYPT is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -60.6% / -65.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
EYPT is held by 21 ETFs as of May 2026. Top owner: VTWO at 0.03% weight, $5M notional. Top 3 carry $14M.
Held by 45 ETFs · $123M across latest filings · largest weight 1.66% (XPH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.03% | $5M | −0.01 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $5M | — |
| VHTVanguard Health Care ETF | 0.02% | $3M | — |
| VFMO | 0.06% | $1M | −0.06 pp |
| ESML | 0.04% | $1M | new |
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.06% |
| $826K |
| −0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $627K | — |
| ONEQ | 0.00% | $381K | — |
| GSSC | 0.04% | $347K | new |
| FSCC | 0.12% | $342K | −0.10 pp |
Showing 10 of 21 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EYPT Jan avg: 6.59% median: 9.61% win: 75% σ: 25.04% n: 4 2022-04-12 → 2026-07-31 | EYPT Feb avg: -3.86% median: -8.50% win: 50% σ: 25.57% n: 4 2022-04-12 → 2026-07-31 | EYPT Mar avg: -19.04% median: -18.80% win: 0% σ: 7.35% n: 4 2022-04-12 → 2026-07-31 | EYPT Apr avg: 24.73% median: 2.40% win: 60% σ: 51.85% n: 5 2022-04-12 → 2026-07-31 | EYPT May avg: -9.68% median: -3.66% win: 40% σ: 18.29% n: 5 2022-04-12 → 2026-07-31 | EYPT Jun avg: 8.37% median: 5.30% win: 60% σ: 28.23% n: 5 2022-04-12 → 2026-07-31 | EYPT Jul avg: 12.65% median: 13.56% win: 80% σ: 21.05% n: 5 2022-04-12 → 2026-07-31 | EYPT Aug avg: -0.70% median: 0.06% win: 50% σ: 17.55% n: 4 2022-04-12 → 2026-07-31 (current) | EYPT Sep avg: -6.98% median: -15.05% win: 25% σ: 20.53% n: 4 2022-04-12 → 2026-07-31 | EYPT Oct avg: -4.32% median: -16.37% win: 25% σ: 35.74% n: 4 2022-04-12 → 2026-07-31 | EYPT Nov avg: -12.09% median: -10.46% win: 50% σ: 25.02% n: 4 2022-04-12 → 2026-07-31 | EYPT Dec avg: 71.63% median: 16.29% win: 75% σ: 133.07% n: 4 2022-04-12 → 2026-07-31 |